| |
A public meeting was held on August 28, 2007, in Washington, DC, to discuss and obtain comments on the draft document, “NIOSH Hazardous Drugs List Update.”
| The
free Adobe Acrobat Reader is needed to view these files. |
 |
| Pre-meeting Information |
| Notice of request for public to submit comments and attend public meeting; 72 FR 33507; 6/18/07 (1 page, 1,290kb) |
| List of new FDA drugs and warnings fitting NIOSH criteria for hazardous drugs; 2006 (3 pages, 2,480kb) |
| NIOSH Alert, “Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings,” DHHS (NIOSH) Publication No. 2004-105 (56 pages, 15,910kb) |
| List of new FDA drugs and warnings not fitting NIOSH criteria for hazardous drugs, 2006 (5
pages, 3,670kb) |
| Meeting Information |
| Presentation by Reed/Connor (NIOSH) at the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07 (16 pages, 2,620kb) |
| List of attendees – 8/27/07 (2 pages, 44kb) |
| Post-Meeting Information |
| Transcript of the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07; Part 1 (121 pages, 22,780kb) |
| Transcript of the NIOSH Public Meeting on Hazardous Drugs List Update; Washington, DC; 8/28/07; Part 2 (52 pages, 20,830kb) |
| Submission to the docket from private person – 6/14/07 (8 pages, 279kb) |
| Submission to the docket from private person – 6/19/07 (1 page,17kb) |
| Submission to the docket from private person – 6/19/07 (1 page, 23kb) |
| Submission to the docket from private person – 6/19/07 (9 pages, 295kb) |
| Submission to the docket from Thies (St. Luke’s Hospital) – 6/22/07 (8 pages, 205kb) |
| Submission to the docket from Olson (GlaxoSmithKline) – 8/1/07 (1 page, 196kb) |
| Submission to the docket from Fabbro (BC Cancer Agency) – 8/24/07 (2 pages, 535kb) |
| Submission to the docket from Werner (The National Home Infusion Association) – 8/27/07 (3 pages, 675kb) |
| Submission to the docket from Schmidt (Western Missouri Mental Health Center) – 8/28/07 (8 pages, 1,490kb) |
| Submission to the docket from private person – 9/6/07 (8 pages, 4,360kb) |
| Submission to the docket from private person – 9/8/07 (8 pages, 177kb) |
| Submission to the docket from Swyres (Barnes-Jewish Hospital) – 9/10/07 (5 pages, 2,690kb) |
| Submission to the docket from private person – 9/11/07 (8 pages, 151kb) |
| Submission to the docket from private person – 9/12/07 (1 page, 20kb) |
| Submission to the docket from Suter (Novartis Pharma AG) – 9/17/07 (5 pages, 984kb) |
| Submission to the docket from Wylie (Wyeth) – 9/18/07 (3 pages, 1,580kb) |
| Submission to the docket from Murano (Genentech, Inc) – 9/18/07 (19 pages, 9,420kb) |
| Submission to the docket from Oliver (AstraZeneca) – 9/19/07 (9 pages, 5,090kb) |
| Submission to the docket from Hung (Mayo Clinic) – 9/19/07 (32 pages, 12,620kb) |
| Submission to the docket from Reilly/Coffey (American Society of Health-System Pharmacists) – 9/20/07 (17 pages, 4,760kb) |
| Submission to the docket from Collura (Clarian Health) – 9/20/07 (8 pages, 1,690kb) |
| Submission to the docket from Roman (Boehringer Ingelheim Pharmaceuticals, Inc) – 9/20/07 (9 pages, 6,420kb) |
| Submission to the docket from Roman (Ben Venue Laboratories) – 9/20/07 (5 pages, 216kb) |
| Submission to the docket from Schwartz (Pfizer Inc) – 9/20/07 (6 pages, 3,090kb) |
| Submission to the docket from Sigler (Kaiser Permanente) – 9/20/07 (6 pages, 153kb) |
| Submission to the docket from Treanor (BioPharma EHS Forum) – 9/20/07 (10 pages, 2,730kb) |
| Submission to the docket from White (Pharmaceutical Research and Manufacturers of America) – 9/20/07 (8 pages, 4,730kb) |
| Submission to the docket from Bough/Gans (American Pharmacists Association) – 9/20/07 (5 pages, 2,870kb) |
| Submission to the docket from Stewart (Kaiser Permanente) – 9/21/07 (6 pages, 186kb) |
| Submission to the docket from Cadsap (Tercica) – 9/26/07 (3 pages, 2,100kb) |
| Submission to the docket from McHugh (Gilead Sciences, Inc) – 9/26/07 (43 pages, 29,120kb) |
| Submission to the docket from Olson (GlaxoSmithKline) – 9/20/07 (11 pages, 2,340kb) |
| Submission to the docket from McGrath (Bristol-Myers Squibb Company) – 9/28/07 (6 pages, 4,830kb) |
| Submission to the docket from Olson (GlaxoSmithKline) – 12/12/07 (13 pages, 420kb) |
| Submission to the docket from Cormack (Sucampo Pharmaceuticals) – 1/22/08 (10 pages, 1,960kb) |
|
 |
|
